Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Simms

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Annals of the Rheumatic Diseases|August 21, 2012
The risk of cardiovascular disease in systemic sclerosis: a population-based cohort studyAda Man, Yanyan Zhu, Yuqing Zhang, et al.
The Journal of Investigative Dermatology|August 16, 2017
Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82Robert Lafyatis, Julio C Mantero, Jessica Gordon, et al.
Archives of Internal Medicine|January 24, 1994
A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritisP A Rochon, J H Gurwitz, R W Simms, et al.
Arthritis Care & Research|February 3, 2025
Geographic Clustering of Systemic Sclerosis in Areas of Environmental PollutionNoelle N Kosarek, Megan E Romano, Erika L Moen, et al.
Arthritis and Rheumatism|July 29, 2006
Durometry for the assessment of skin disease in systemic sclerosisEugene Y Kissin, Aileen M Schiller, Rondi B Gelbard, et al.
Arthritis and Rheumatism|June 1, 1994
Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolismR W Simms, S H Roy, M Hrovat, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 1, 2003
Beta 2 microglobulin serum levels and prediction of survival in AL amyloidosisCristiano A F Zerbini, Jennifer J Anderson, Kelly A Kane, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2017
Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic SclerosisMichelle Fleury, Anna C Belkina, Elizabeth A Proctor, et al.
Clinical and Experimental Rheumatology|October 3, 2018
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trialJulio C Mantero, Nina Kishore, Jessica Ziemek, et al.
Arthritis Research & Therapy|August 18, 2018
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosisLisa M Rice, Julio C Mantero, Eric A Stratton, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Annals of the Rheumatic Diseases|August 21, 2012
The risk of cardiovascular disease in systemic sclerosis: a population-based cohort studyAda Man, Yanyan Zhu, Yuqing Zhang, et al.
The Journal of Investigative Dermatology|August 16, 2017
Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82Robert Lafyatis, Julio C Mantero, Jessica Gordon, et al.
Archives of Internal Medicine|January 24, 1994
A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritisP A Rochon, J H Gurwitz, R W Simms, et al.
Arthritis Care & Research|February 3, 2025
Geographic Clustering of Systemic Sclerosis in Areas of Environmental PollutionNoelle N Kosarek, Megan E Romano, Erika L Moen, et al.
Arthritis and Rheumatism|July 29, 2006
Durometry for the assessment of skin disease in systemic sclerosisEugene Y Kissin, Aileen M Schiller, Rondi B Gelbard, et al.
Arthritis and Rheumatism|June 1, 1994
Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolismR W Simms, S H Roy, M Hrovat, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 1, 2003
Beta 2 microglobulin serum levels and prediction of survival in AL amyloidosisCristiano A F Zerbini, Jennifer J Anderson, Kelly A Kane, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2017
Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic SclerosisMichelle Fleury, Anna C Belkina, Elizabeth A Proctor, et al.
Clinical and Experimental Rheumatology|October 3, 2018
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trialJulio C Mantero, Nina Kishore, Jessica Ziemek, et al.
Arthritis Research & Therapy|August 18, 2018
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosisLisa M Rice, Julio C Mantero, Eric A Stratton, et al.
Pageof 8